230 related articles for article (PubMed ID: 21129127)
1. Hepatitis A outbreaks: the effect of a mass vaccination programme.
Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
[TBL] [Abstract][Full Text] [Related]
2. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
[TBL] [Abstract][Full Text] [Related]
3. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction.
Domínguez A; Oviedo M; Carmona G; Batalla J; Bruguera M; Salleras L; Plasència A
Vaccine; 2008 Mar; 26(14):1737-41. PubMed ID: 18325642
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
[TBL] [Abstract][Full Text] [Related]
6. A statistical model to estimate the impact of a hepatitis A vaccination programme.
Oviedo M; Pilar Muñoz M; Domínguez A; Borras E; Carmona G
Vaccine; 2008 Nov; 26(48):6157-64. PubMed ID: 18804511
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A in Australia in the 1990s: future directions in surveillance and control.
Amin J; Heath T; Morrell S
Commun Dis Intell; 1999 May; 23(5):113-20. PubMed ID: 10429311
[TBL] [Abstract][Full Text] [Related]
8. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Hepatitis A in Argentina after vaccination.
Vacchino MN
J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
[TBL] [Abstract][Full Text] [Related]
11. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y
Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis A disease following the implementation of universal vaccination: who is at risk?
Mor Z; Srur S; Dagan R; Rishpon S
J Viral Hepat; 2010 Apr; 17(4):293-7. PubMed ID: 19691457
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis A in Poland in 2009].
Baumann-Popczyk A
Przegl Epidemiol; 2011; 65(2):255-8. PubMed ID: 21913470
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis A in Poland in the years 2006-2007].
Baumann A
Przegl Epidemiol; 2009; 63(2):241-4. PubMed ID: 19799253
[TBL] [Abstract][Full Text] [Related]
16. Universal hepatitis A vaccination in the United States: a call for action.
Lieberman JM; Word BM; Jacobs RJ; Dagan R; Marchant CD
Pediatr Infect Dis J; 2008 Apr; 27(4):287-91. PubMed ID: 18316993
[TBL] [Abstract][Full Text] [Related]
17. Cost-benefit analysis of hepatitis a vaccination in Thailand.
Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis A in Poland in 2008].
Baumann A
Przegl Epidemiol; 2010; 64(2):235-7. PubMed ID: 20731228
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility of universal hepatitis A vaccination in Canada.
Bauch CT; Anonychuk AM; Pham BZ; Gilca V; Duval B; Krahn MD
Vaccine; 2007 Dec; 25(51):8536-48. PubMed ID: 17996339
[TBL] [Abstract][Full Text] [Related]
20. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain).
Salleras L; Dominguez A; Bruguera M; Cardeñosa N; Batalla J; Carmona G; Navas E; Taberner JL
Vaccine; 2005 Mar; 23(17-18):2181-4. PubMed ID: 15755591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]